A Single-Blind, Randomized, Monocentric Phase II Trial to Explore the Safety and Rabies-Neutralizing Activity of Combined Administration of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin Plus Rabies Vaccine in Simulated Rabies Post-Exposure Prophylaxis in Children and Adolescents.
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2012
At a glance
- Drugs Foravirumab; Rabies immune globulin; Rabies vaccine
- Indications Rabies
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Crucell
- 20 Oct 2009 Results have been presented in a Crucell media release.
- 24 Jun 2009 Status changed from active, no longer recruiting to completed.
- 27 May 2008 New trial record.